Treace Medical Concepts (TMCI)
(Real Time Quote from BATS)
$5.88 USD
+0.08 (1.38%)
Updated Sep 27, 2024 02:16 PM ET
3-Hold of 5 3
D Value C Growth C Momentum C VGM
Treace Medical Concepts (TMCI) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$8.86 | $17.00 | $7.00 | 52.76% |
Price Target
Based on short-term price targets offered by seven analysts, the average price target for Treace Medical Concepts comes to $8.86. The forecasts range from a low of $7.00 to a high of $17.00. The average price target represents an increase of 52.76% from the last closing price of $5.80.
Analyst Price Targets (7 )
Broker Rating
Treace Medical Concepts currently has an average brokerage recommendation (ABR) of 3.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 3.00 a month ago based on seven recommendations.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 7 | 7 | 7 | 7 | 7 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/5/2024 | Stephens | George Sellers | Hold | Hold |
8/7/2024 | Truist Securities | Richard Newitter | Hold | Hold |
5/16/2024 | UBS | Danielle Antalffy | Strong Buy | Hold |
5/8/2024 | Not Identified | Not Identified | Strong Buy | Hold |
5/8/2024 | BTIG | Ryan Zimmerman | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 3.00 |
ABR (Last week) | 3.00 |
# of Recs in ABR | 7 |
Average Target Price | $8.86 |
LT Growth Rate | NA |
Industry | Medical - Instruments |
Industry Rank by ABR | 67 of 253 |
Current Quarter EPS Est: | -0.27 |
TMCI FAQs
Treace Medical Concepts, Inc. (TMCI) currently has an average brokerage recommendation (ABR) of 3.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 7 brokerage firms.
The average price target for Treace Medical Concepts, Inc. (TMCI) is $8.86. The current on short-term price targets is based on 5 reports.
The forecasts for Treace Medical Concepts, Inc. (TMCI) range from a low of $7 to a high of $17. The average price target represents a increase of $52.76 from the last closing price of $5.80.
The current UPSIDE for Treace Medical Concepts, Inc. (TMCI) is 52.76%
Based on short-term price targets offered by seven analysts, the average price target for Treace Medical Concepts comes to $8.86. The forecasts range from a low of $7.00 to a high of $17.00. The average price target represents an increase of 52.76% from the last closing price of $5.80.